Indian drug manufacturer agrees to pay $50 million fine for concealing and deleting records before FDA inspection
Indian drugmaker Fresenius Kabi Oncology Limited (FKOL) was charged for violating the Federal Food, Drug, and Cosmetic Act. The US Department of Justice (DOJ) announced that an Indian drug-making firm has agreed to plead guilty to concealing and destroying records...